2 followers
Bringing hope and relief to patients with undertreated rare diseases through the development and commercialization of curative first-in-class gene-modified cell therapies.
Gaurav Shah
Bristol-Myers Squibb
185 followers
Karyopharm Therapeutics
12 followers
Rimsys
2 followers
Grassroots Analytics
54 followers
University of California, Irvine
15 followers
Ethos Support
14 followers
Unite America
1 follower
FirstMark
7 followers
Charlie Health
5 followers
Shyft Group
3 followers
Novartis
226 followers
Explore companies